The firm will acquire PerkinElmer’s OneSource laboratory and field services, along with a portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents that serve the biopharma, food, environmental and safety, and other markets. New Mountain Capital is a New York-based investment firm with approximately $37 billion in assets. Enter the PerkinElmer catalog number of your. The result of this search will be the Certificate of Analysis specific to that lot number. Begin your search by entering one of the following: Enter the lot number of your product (e.g. Perkinelmer stock is currently +17.95 from its 52-week low of 130.65, and -24.15 from its 52-week high of 203.16. It has overperformed other stocks in the Diagnostics & Research industry by 0.1 percentage points. “With today’s divestiture announcement, we position the company to transform into a pureplay, high growth, high margin life sciences and diagnostics company with even more focus to capitalize on attractive end markets,” Singh said in a statement. PerkinElmer now archives lot-specific Certificates of Analysis for selected products. stock last closed at 154.10, up 0.08 from the previous day, and has decreased 16.66 in one year. Prahlad Singh, president and chief executive officer of PerkinElmer, said the sale allows the company to focus on maximizing growth in the diagnostics and life sciences markets, while increasing financial flexibility.